These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 15596215)

  • 21. Screening, identification of prostate cancer urinary biomarkers and verification of important spots.
    Zhao H; Zhao X; Lei T; Zhang M
    Invest New Drugs; 2019 Oct; 37(5):935-947. PubMed ID: 30610587
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of mRNA, Protein, and Urinary Nucleic Acid Levels of S100A8 and S100A9 between Prostate Cancer and BPH.
    Yun SJ; Yan C; Jeong P; Kang HW; Kim YH; Kim EA; Lee OJ; Kim WT; Moon SK; Kim IY; Choi YH; Kim WJ
    Ann Surg Oncol; 2015 Jul; 22(7):2439-45. PubMed ID: 25348783
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Serum proteomic study of prostate cancer with bone metastasis].
    Zhang XM; Shen Y; Xianyu ZQ
    Zhonghua Nan Ke Xue; 2010 Aug; 16(8):721-5. PubMed ID: 21090348
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Zinc α2-glycoprotein as a potential novel urine biomarker for the early diagnosis of prostate cancer.
    Katafigiotis I; Tyritzis SI; Stravodimos KG; Alamanis C; Pavlakis K; Vlahou A; Makridakis M; Katafigioti A; Garbis SD; Constantinides CA
    BJU Int; 2012 Dec; 110(11 Pt B):E688-93. PubMed ID: 23020913
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential proteome analysis of conditioned medium of BPH-1 and LNCaP cells.
    Chen WZ; Pang B; Yang B; Zhou JG; Sun YH
    Chin Med J (Engl); 2011 Nov; 124(22):3806-9. PubMed ID: 22340245
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical collection and protein properties of expressed prostatic secretions as a source for biomarkers of prostatic disease.
    Drake RR; White KY; Fuller TW; Igwe E; Clements MA; Nyalwidhe JO; Given RW; Lance RS; Semmes OJ
    J Proteomics; 2009 Aug; 72(6):907-17. PubMed ID: 19457353
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of proteomic components of sera from patients with uremia by two dimensional electrophoresis and matrix assisted laser desorption/ ionization time of flight mass spectrometry.
    Wang J; Dai Y; Deng A; Liu J
    J Huazhong Univ Sci Technolog Med Sci; 2005; 25(5):604-7. PubMed ID: 16463688
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DNA-based detection of prostate cancer in urine after prostatic massage.
    Goessl C; Müller M; Heicappell R; Krause H; Straub B; Schrader M; Miller K
    Urology; 2001 Sep; 58(3):335-8. PubMed ID: 11549474
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MALDI-MS tissue imaging identification of biliverdin reductase B overexpression in prostate cancer.
    Pallua JD; Schaefer G; Seifarth C; Becker M; Meding S; Rauser S; Walch A; Handler M; Netzer M; Popovscaia M; Osl M; Baumgartner C; Lindner H; Kremser L; Sarg B; Bartsch G; Huck CW; Bonn GK; Klocker H
    J Proteomics; 2013 Oct; 91():500-14. PubMed ID: 23954705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urinary Polyamines: A Pilot Study on Their Roles as Prostate Cancer Detection Biomarkers.
    Tsoi TH; Chan CF; Chan WL; Chiu KF; Wong WT; Ng CF; Wong KL
    PLoS One; 2016; 11(9):e0162217. PubMed ID: 27598335
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Analyzing urinary proteome patterns of metabolic syndrome patients with early renal injury by magnet bead separation and matrix-assisted laser desorption ionization time-of-flight mass spectrometry].
    Gao BX; Li MX; Liu XJ; Cai JF; Fan XH; Yang XL; Li XM; Li XW
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2011 Oct; 33(5):511-6. PubMed ID: 22338134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of two-dimensionally separated human cerebrospinal fluid proteins by N-terminal sequencing, matrix-assisted laser desorption/ionization--mass spectrometry, nanoliquid chromatography-electrospray ionization-time of flight-mass spectrometry, and tandem mass spectrometry.
    Raymackers J; Daniels A; De Brabandere V; Missiaen C; Dauwe M; Verhaert P; Vanmechelen E; Meheus L
    Electrophoresis; 2000 Jun; 21(11):2266-83. PubMed ID: 10892737
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prostate cancer antigen 3 gene expression in peripheral blood and urine sediments from prostate cancer and benign prostatic hyperplasia patients versus healthy individuals.
    Moradi Sardareh H; Goodarzi MT; Yadegar-Azari R; Poorolajal J; Mousavi-Bahar SH; Saidijam M
    Urol J; 2014 Nov; 11(6):1952-8. PubMed ID: 25433473
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urine of patients with early prostate cancer contains lower levels of light chain fragments of inter-alpha-trypsin inhibitor and saposin B but increased expression of an inter-alpha-trypsin inhibitor heavy chain 4 fragment.
    Jayapalan JJ; Ng KL; Shuib AS; Razack AH; Hashim OH
    Electrophoresis; 2013 Jun; 34(11):1663-9. PubMed ID: 23417432
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimization of analytical and pre-analytical conditions for MALDI-TOF-MS human urine protein profiles.
    Calvano CD; Aresta A; Iacovone M; De Benedetto GE; Zambonin CG; Battaglia M; Ditonno P; Rutigliano M; Bettocchi C
    J Pharm Biomed Anal; 2010 Mar; 51(4):907-14. PubMed ID: 19939598
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potential plasma biomarkers of bladder cancer identified by proteomic analysis: A pilot study.
    Lemańska-Perek A; Lis-Kuberka J; Lepczyński A; Dratwa-Chałupnik A; Tupikowski K; Kątnik-Prastowska I; Ożgo M
    Adv Clin Exp Med; 2019 Mar; 28(3):339-346. PubMed ID: 29963784
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Collagen cross-link metabolites in urine as markers of bone metastases in prostatic carcinoma.
    Miyamoto KK; McSherry SA; Robins SP; Besterman JM; Mohler JL
    J Urol; 1994 Apr; 151(4):909-13. PubMed ID: 7510346
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Normal, benign, preneoplastic, and malignant prostate cells have distinct protein expression profiles resolved by surface enhanced laser desorption/ionization mass spectrometry.
    Cazares LH; Adam BL; Ward MD; Nasim S; Schellhammer PF; Semmes OJ; Wright GL
    Clin Cancer Res; 2002 Aug; 8(8):2541-52. PubMed ID: 12171882
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urinary CD14 as a potential biomarker for benign prostatic hyperplasia - discovery by combining MALDI-TOF-based biostatistics and ESI-MS/MS-based stable-isotope labeling.
    Cheng HL; Huang HJ; Ou BY; Chow NH; Chen YW; Tzai TS; Wu CJ; Chen SH
    Proteomics Clin Appl; 2011 Apr; 5(3-4):121-32. PubMed ID: 21322116
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proteomics in diagnosis of prostate cancer.
    Davalieva K; Polenakovic M
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2015; 36(1):5-36. PubMed ID: 26076772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.